The global ophthalmic lasers market is expected to witness considerable growth during the forecast period owing to rising demand of ophthalmic lasers for the treatment of various diseases, such as glaucoma, age related macular degeneration (AMD), cataract and diabetic retinopathy. The players in the ophthalmic lasers market offer products such as; femtosecond lasers, excimer lasers, nd: yag lasers, diode lasers, SLT lasers and other lasers. Among these, femtosecond lasers are expected to hold the largest share in 2017, due to increasing prevalence of refractive errors in aging and young population.
Request to Get the Sample Pages at: https://www.psmarketresearch.com/market-analysis/ophthalmic-lasers-market/report-sample
Increasing prevalence of cataract, rising number of hospitals, increasing government initiatives, and rising awareness about the advanced laser technologies in developing countries create ample opportunities for the market players to introduce novel ophthalmic laser therapies. According to International Diabetes Federation (IDB) report in 2016, around 80% of the world’s diabetes retinopathy patients resides in developing countries.
Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=ophthalmic-lasers-market
North America is expected to hold the largest share of the ophthalmic
lasers market in 2017, followed by the Europe. The growth in the North American
ophthalmic lasers market is mainly attributed to the increasing chronic eye
diseases, rising aging population, and developed healthcare reimbursement
structure in the region. Asia-Pacific is expected to showcase the fastest growth
in demand in the ophthalmic lasers market during the forecast period. This
growth can be attributed to the increasing healthcare expenditure, growing
medical tourism, and rising awareness about technologically advanced laser
treatments.
Some of the other players in the ophthalmic lasers industry include, Novartis
AG, Topcon Corporations, Ellex Medical Lasers Ltd, QUANTEL SA, IRIDEX
Corporation, NIDEK CO Ltd., LMENIS LTD, Abbott Laboratories and Ziemer
Ophthalmic Systems AG.